ID20742A - Penggunaan donor-donor oksida nitrat dan/atau untuk mengatur pelebaran dan perluasan leher rahim - Google Patents

Penggunaan donor-donor oksida nitrat dan/atau untuk mengatur pelebaran dan perluasan leher rahim

Info

Publication number
ID20742A
ID20742A IDP960631A ID960631A ID20742A ID 20742 A ID20742 A ID 20742A ID P960631 A IDP960631 A ID P960631A ID 960631 A ID960631 A ID 960631A ID 20742 A ID20742 A ID 20742A
Authority
ID
Indonesia
Prior art keywords
expansion
nitric oxide
regulation
donors
oxidate
Prior art date
Application number
IDP960631A
Other languages
English (en)
Inventor
Kristof Dr Chwalisz
Robert E Garfield
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of ID20742A publication Critical patent/ID20742A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/223—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
IDP960631A 1995-03-14 1996-03-14 Penggunaan donor-donor oksida nitrat dan/atau untuk mengatur pelebaran dan perluasan leher rahim ID20742A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95250059 1995-03-14

Publications (1)

Publication Number Publication Date
ID20742A true ID20742A (id) 1999-02-25

Family

ID=8221039

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP960631A ID20742A (id) 1995-03-14 1996-03-14 Penggunaan donor-donor oksida nitrat dan/atau untuk mengatur pelebaran dan perluasan leher rahim

Country Status (26)

Country Link
US (1) US6333350B1 (id)
EP (1) EP0814785B1 (id)
JP (1) JP4579349B2 (id)
KR (2) KR100434239B1 (id)
CN (1) CN1151781C (id)
AT (1) ATE377417T1 (id)
AU (1) AU713172B2 (id)
CA (1) CA2214779A1 (id)
CZ (1) CZ292395B6 (id)
DE (1) DE69637313T2 (id)
ES (1) ES2297838T3 (id)
HU (1) HUP9800826A3 (id)
ID (1) ID20742A (id)
IL (1) IL117496A (id)
IS (1) IS4555A (id)
MX (1) MX9707007A (id)
MY (1) MY116500A (id)
NO (1) NO318598B1 (id)
NZ (1) NZ305169A (id)
PL (1) PL183461B1 (id)
RU (1) RU2199346C2 (id)
SK (1) SK124197A3 (id)
TW (1) TW421594B (id)
UA (1) UA57703C2 (id)
WO (1) WO1996028145A1 (id)
ZA (1) ZA962089B (id)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA57703C2 (uk) 1995-03-14 2003-07-15 Шерінг Актієнгезеллшафт Спосіб стимуляції та спосіб інгібування дозрівання шийки матки
EP0889724A1 (en) * 1996-02-27 1999-01-13 Rpms Technology Limited Cox-2 selective inhibitors for managing labour and uterine contractions
US6232434B1 (en) 1996-08-02 2001-05-15 Duke University Medical Center Polymers for delivering nitric oxide in vivo
DE19809845A1 (de) 1998-03-03 1999-09-09 Jenapharm Gmbh S-substituierte 11beta-Benzaldoxim-estra-4,9-dien-kohlensäurethiolester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
ITMI20002117A1 (it) * 2000-09-29 2002-03-29 Ibsa Inst Biochimique Sa Uso di sodio nitroprussiato in ostetricia e ginecologia
WO2005023189A2 (en) * 2003-09-03 2005-03-17 Pharmacia Corporation Method of cox-2 selective inhibitor and nitric oxide-donating agent
RU2267133C2 (ru) * 2004-03-04 2005-12-27 Государственное учреждение "Ивановский научно-исследовательский институт материнства и детства им. В.Н. Городкова" Минздрава России Способ диагностики угрозы преждевременных родов
WO2006089561A1 (en) * 2005-02-23 2006-08-31 Abbas Abdelsalam Ghazi Pharmaceutical compositions containing organic acids useful for softening and ripening uterine cervix.
US8828981B2 (en) 2007-02-06 2014-09-09 George Creasy Progesterone for the treatment or prevention of spontaneous preterm birth
CN102283827A (zh) * 2008-10-16 2011-12-21 四川维信医药科技有限责任公司 单硝酸异山梨酯的新用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU668107B2 (en) * 1991-09-24 1996-04-26 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The Oxygen substituted derivatives of nucleophile-nitric oxide adducts as nitric oxide donor prodrugs
US5508045A (en) 1992-10-09 1996-04-16 The Regents Of The University Of California Method and agents for control and management of labor during pregnancy
US5895783A (en) * 1993-07-16 1999-04-20 Schering Aktiengesellschaft Treatment of preeclampsia and preterm labor with combination of progestational agent and a nitric oxide synthase substrate and/or donor
PL178174B1 (pl) * 1993-11-16 2000-03-31 Garfield Robert E Kompozycje farmaceutyczne do hamowania kurczliwości macicy lub stymulowania kurczliwości macicy
US5550369A (en) 1994-02-28 1996-08-27 Electro-Pro, Inc. Triangulation position detection method and apparatus
UA57703C2 (uk) 1995-03-14 2003-07-15 Шерінг Актієнгезеллшафт Спосіб стимуляції та спосіб інгібування дозрівання шийки матки

Also Published As

Publication number Publication date
NO974204L (no) 1997-11-13
IS4555A (is) 1997-09-05
CN1151781C (zh) 2004-06-02
IL117496A0 (en) 1997-03-18
IL117496A (en) 2002-12-01
AU713172B2 (en) 1999-11-25
CZ292395B6 (cs) 2003-09-17
DE69637313D1 (de) 2007-12-20
KR100434238B1 (ko) 2004-07-16
JP4579349B2 (ja) 2010-11-10
JPH11502200A (ja) 1999-02-23
SK124197A3 (en) 1998-06-03
MX9707007A (es) 1998-06-30
ATE377417T1 (de) 2007-11-15
HUP9800826A1 (hu) 1998-07-28
ZA962089B (en) 1997-08-27
KR20040004515A (ko) 2004-01-13
RU2199346C2 (ru) 2003-02-27
MY116500A (en) 2004-02-28
KR19980703060A (ko) 1998-09-05
TW421594B (en) 2001-02-11
CZ285197A3 (cs) 1998-03-18
NO318598B1 (no) 2005-04-18
EP0814785A1 (en) 1998-01-07
UA57703C2 (uk) 2003-07-15
CN1182366A (zh) 1998-05-20
ES2297838T3 (es) 2008-05-01
HUP9800826A3 (en) 1998-08-28
WO1996028145A1 (en) 1996-09-19
US6333350B1 (en) 2001-12-25
KR100434239B1 (ko) 2004-06-09
CA2214779A1 (en) 1996-09-19
EP0814785B1 (en) 2007-11-07
NO974204D0 (no) 1997-09-12
NZ305169A (en) 1999-10-28
PL183461B1 (pl) 2002-06-28
DE69637313T2 (de) 2008-09-04
PL322252A1 (en) 1998-01-19
AU5311796A (en) 1996-10-02

Similar Documents

Publication Publication Date Title
WO1995033464A3 (en) Retroviral protease inhibitor combinations
DE69534755D1 (de) Vorrichtung für die Verabreichung von Phosphodiesterase-Hemmern
NO932388D0 (no) Fremgangsmaate til fraktur-syrebehandling av undervannsformasjoner
DK0690851T3 (da) Guanidin-derivater, som er anvendelige til behandling
WO1994012165A3 (en) Enzyme inhibitors
AU1467888A (en) Agent for the prophylaxis and therapy of retroviral infections
DE69221501D1 (de) Verfahren zum vermindern von durch medizinische vorrichtungen bedingten infektionen
NO961994D0 (no) Behandling av klimakteriske forstyrrelser med nitrogenoksidsyntasesubstrater og/eller -donorer
AU5635396A (en) Alpha-substituted pyrimidine-thioalkyl and alkylether compounds
NO953308D0 (no) Inhibitorer av HIV revers transkriptase
NO974204L (no) Anvendelse av nitrogenoksiddonorer eller nitrogenoksidinhibitorer for regulering av cervixdilatasjon og -utvidelsesevne
DE59308256D1 (de) Dexpanthenol-haltiges pflaster zur transdermalen applikation von steroidhormonen
ATE202599T1 (de) Mit isoliertem empfindlichem x-syndrom verbundene dns-sequenzen
NO943597L (no) Klebende/mekanisk festesystem for kasserbar absorberend gjenstand
NO960775L (no) Anvendelse av kinoksaliner i kombinasjon med proteaseinhibitorer som legemiddel for behandling av AIDS og/eller HIV-infeksjoner
DE69632632D1 (de) Behandlungsverfahren für darmadenome
DE69327248D1 (de) Verfahren zur behandlung des symptomenkomplexes des prämenstruellen syndroms mit vitamin d oder vitamin d und calcium
PT730448E (pt) Utilizacao de um substrato de sintetase e/ou dador de oxido nitrico ou um inibidor de oxido nitrico para o fabrico de medicamentos para o tratamento de desordens da contractilidade uterina
CZ157795A3 (en) Pharmaceutical preparations for treating prostatitis
BR9307692A (pt) Artigo absorvente
FI950696A0 (fi) Menetelmä HIV:n replikaation estämiseksi IL-4:ää käyttämällä
NO20002481L (no) Kombinasjonsterapi for behandling av AIDS
NO951608L (no) Anvendelse av BHAP-forbindelser i kombinasjon med andre ikke-nukleoside reverstranskriptaseinhibitorer for behandling av HIV-infeksjon
NO962503L (no) Anvendelse av penoksyfyllin ved behandling av multippel sklerose
DK0697885T3 (da) Insulinlignende vækstfaktor II som antitumormiddel